Literature DB >> 24162274

Effective tuberculosis and hepatitis screening prior to anti-TNF-α therapy: are we there yet?

Neal Shahidi1, Brian Bressler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24162274     DOI： 10.1007/s10620-013-2919-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Neal Shahidi; Yi-Tzu Nancy Fu; Hong Qian; Brian Bressler
Journal:  Inflamm Bowel Dis       Date:  2012-01-31       Impact factor: 5.325

Review 2.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

Review 3.  A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy.

Authors:  Mohsen Sadatsafavi; Neal Shahidi; Fawziah Marra; Mark J FitzGerald; Kevin R Elwood; Na Guo; Carlo A Marra
Journal:  J Clin Epidemiol       Date:  2009-08-18       Impact factor: 6.437

Review 4.  Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.

Authors:  Adithya Cattamanchi; Rachel Smith; Karen R Steingart; John Z Metcalfe; Anand Date; Courtney Coleman; Barbara J Marston; Laurence Huang; Philip C Hopewell; Madhukar Pai
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

Review 5.  Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Authors:  Madhukar Pai; Alice Zwerling; Dick Menzies
Journal:  Ann Intern Med       Date:  2008-06-30       Impact factor: 25.391

Review 6.  Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge.

Authors:  Majid Abdulrahman Almadi; Subrata Ghosh; Abdulrahman Mohamed Aljebreen
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

7.  Optimizing screening for tuberculosis and hepatitis B prior to starting tumor necrosis factor-α inhibitors in Crohn's disease.

Authors:  Mike van der Have; Bas Oldenburg; Herma H Fidder; Tim D G Belderbos; Peter D Siersema; Martijn G H van Oijen
Journal:  Dig Dis Sci       Date:  2013-08-15       Impact factor: 3.199

8.  European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

Authors:  J F Rahier; S Ben-Horin; Y Chowers; C Conlon; P De Munter; G D'Haens; E Domènech; R Eliakim; A Eser; J Frater; M Gassull; M Giladi; A Kaser; M Lémann; T Moreels; A Moschen; R Pollok; W Reinisch; M Schunter; E F Stange; H Tilg; G Van Assche; N Viget; B Vucelic; A Walsh; G Weiss; Y Yazdanpanah; Y Zabana; S P L Travis; J F Colombel
Journal:  J Crohns Colitis       Date:  2009-04-26       Impact factor: 9.071
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.